Clinical Trial Update: QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating QL1706 in combination with Celecoxib for advanced esophageal squamous cell carcinoma; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Celecoxib (Celecoxib)
• QL1706

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING